If states, including California, proceed with a penalty scaled to the full spending gap, they should recognize that they are essentially setting a global budget—and that effective global budgets need ...

The agency has failed to consider ways in which industry influence can shape the patient voices that the FDA hears.

It’s worth taking the time to institute practices that ensure this money is used in ways that honor the tens of thousands of ...

Addiction science has produced practical, life-saving knowledge because federal research has been guided by rigorous peer ...

Addressing the physician and nurse shortages will require both upstream interventions that build a shared health career pipeline and downstream investments that expand the distinct training capacities ...

Congress should give employers a more accountable and affordable option to administer their medical benefit plans.

The advent of cell and gene therapies heralds a powerful shift, but without deliberate attention to financing, delivery, data ...

The concept rests on assumptions that are unsupported by evidence. Consequently, current proposals for mandatory ...

Housing First has a strong and extensive evidence base demonstrating that it improves housing stability. Findings on health outcomes and costs are mixed, although it is not clear whether this reflects ...

Despite a lack of evidence of clinical benefit and substantial safety and quality concerns, an FDA advisory committee narrowly supported adding seven peptide substances to the pharmacy compounding ...

Exhibit 1 National health expenditures (NHE) and personal health care (PHC) expenditures, aggregate and per capita amounts, share of gross domestic product (GDP), and annual growth, selected calendar ...

The ACA has touched the lives of every American, proving that improving the U.S. health system is possible. It can, and demonstrably should, inform further improvements. At its 15th anniversary, the ...